The EMIT (Enzyme Multiplied Immunoassay Technique) for serun gentamicin determination was evaluated by a standard procedure. The precision, accuracy, and specificity were assessed and proved satisfactory. Comparison with a bioassay was done, and results for patient samples showed a correlation coefficient of 0.95 between the two methods. Advantages of the enzyme immunoassay system were the provision of results within 15 min of receipt of blood in the laboratory, a requirement of minimal technical expertise, and an applicability to both large and small workloads. The EMIT proved during evaluation to be a practical alternative to current bioassays for the determination of serum gentamicin concentrations.
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Gentamicin is an important broad-spectrum antibiotic, but it possesses a significant potential for toxicity. Due to the relatively small difference between therapeutic and toxic levels, serum assays are necessary for good patient management (9) .
Microbiological assays (4), although shown to be slow, inaccurate, and lacking in specificity, have been the most frequently used assay systems for the determination of serum gentamicin concentrations (9, 10) .
Several altemative methods, viz. adenylation and acetylation (3, 12) , radioimmunoassay (7) , fluorescence quenching (1), and high-pressure liquid chromatography, have been described (2) . Although these assays lead to increased specificity and accuracy, several drawbacks, such as the problem of the disposal of radioisotopes and the requirement for special technical skills, detract from their advantages (8) .
The EMIT (Enzyme Multiplied Immunoassay Technique) methodology first introduced by Syva in 1974 has been used for several years for the determination of the antiepileptic drugs phenytoin, carbamazepine, and phenobarbitone (11) . In brief, the technique depends upon the direct competition between a drug in the patient's serum and the same drug covalently bound to an enzyme for sites on an antibody directed against the drug. When enzyme-labeled drug is bound to the antibody, its activity is greatly reduced, and the amount so bound is a function of the concentration of drug in the patient's serum. Thus, the enzyme activity remaining in the test system is likewise related to the serum drug concentration. The latter is determined by comparing the enzyme activity with that produced by a series of standard solutions of the same drug.
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In this evaluation the accuracy, reproducibility, and specificity of an enzyme immunoassay for gentamicin were studied. Results for patient samples were compared with those obtained for a microbiological assay. The Incubation time is either 4 or 16 h. The assay used is affected by the presence of erythromycin, cindamycin, co-trimoxazole, and cefoxitin. Patient samples for this study were randomly selected from routine samples submitted for assay. Quality control samples were prepared by adding gentamicin to drug-free serum.
RESULTS
Reproducibility. Between-batch reproducibility was assessed by analyzing control materials containing gentamicin at three different concentrations 15 times over a period of two months. The control materials were also analyzed 10 times within the same run to provide within-batch reproducibility data. The results are presented in Table 1 Specificity. Interference in the assay was assessed by adding to serum known amounts of a wide range of antibiotics and determining if any apparent "gentamicin" levels were obtained. The antibiotics kanamycin, streptomycin, ampicillin, clindamycin, tobramycin, sulfamethoxazole/trimethoprim, neomycin, and amikacin were added to the serum at concentrations at least double the normal therapeutic concentrations. No apparent "gentamicin" was detected.
For investigating whether carbenicillin and ticarcillin have any degradative effect on the gentamicin molecule that is detectable by this method, carbenicillin and ticarcillin were added separately at a concentration of 250 mg/liter to serum containing 5.5 mg of gentamicin per liter and assayed at 15 min and 48 h. Both antibiotics caused detectable degradation (20% for carbenicillin and 25% for ticarcillin) between the two times.
Stability. A total of 10 serum samples were analyzed as soon as possible after collection. Five of these were stored at 40C and analyzed on the following 4 day, provided that the same lot of reagents is used. The specificity studies indicate that the assay system is free from interference from other antibiotics likely to be administered concomitantly with gentamicin. The manufacturers state that the antibiotics netilmicin and sisomicin can cross react. However, neither of these antibiotics is likely to be administered concurrently with gentamicin. The results for the experiments with the antibiotics carbenicillin and ticarcillin confirmn those described previously (5) , in which it was shown that, in vitro, both antibiotics caused a decrease in bioactive gentamicin concentrations. Because the enzyme immunoassay uses an antibody specific to the intact gentamicin molecule, the results indicate that any degradation products of gentamicin produced by carbenicillin and ticarcillin do not appear to interact with the antibody in the assay system. The stability studies at 4 and -20°C demonstrate that the effects of storage, such as the release of serum components, e.g., free fatty acids (6), do not affect the measurement of serum gentamicin concentrations. The patient comparison data with statistical analysis between the bioassay and the EMIT is acceptable.
Over the period of the evaluation, several advantages of the EMIT became apparent. These are the low degree of technical expertise required, the suitability for both large and small work loads, the freedom from interference by antibiotics most likely to be administered concomitantly with gentamicin, the rapidity of results (i.e., within 15 min), and finally, the expediency of this method to the performance of urgent assays.
In conclusion, the enzyme immunoassay tech-ANTIMICROB. AGENTS CHEMOTHER.
nique for gentamicin performed satisfactorily during the period of evaluation. The acceptable precision and accuracy of the assay, combined with the rapid generation of results, make the EMIT a significant improvement over existing microbiological assays.
